国产aaaa级全身裸体精油片_337p人体粉嫩久久久红粉影视_一区中文字幕在线观看_国产亚洲精品一区二区_欧美裸体男粗大1609_午夜亚洲激情电影av_黄色小说入口_日本精品久久久久中文字幕_少妇思春三a级_亚洲视频自拍偷拍

首頁(yè) > 行業(yè)資訊 > 2023年Organic Process Research & Development期刊年度優(yōu)秀論文獎(jiǎng)公布

2023年Organic Process Research & Development期刊年度優(yōu)秀論文獎(jiǎng)公布

時(shí)間:2023-06-08 來(lái)源: 瀏覽:

2023年Organic Process Research & Development期刊年度優(yōu)秀論文獎(jiǎng)公布

原創(chuàng) ACS Publications ACS美國(guó)化學(xué)會(huì)
ACS美國(guó)化學(xué)會(huì)

gh_0320d0d498b4

ACS作為權(quán)威科學(xué)信息的主要來(lái)源,是全球化學(xué)企業(yè)、化學(xué)家、化學(xué)工程師和相關(guān)人員的職業(yè)家園。

收錄于合集
#Org. Process Res. Dev. 1 個(gè)
#有機(jī)化學(xué) 22 個(gè)

Lectureship Award 

近日, Organic Process Research & Development期刊與美國(guó)化學(xué)會(huì)有機(jī)化學(xué)學(xué)部共同頒布了 Organic Process Research & Development 期刊 年度優(yōu)秀論文獎(jiǎng) 的首屆獲獎(jiǎng)?wù)撸麄兪牵篔ason M. Stevens, Eric M. Simmons, Yichen Tan, Alina Borovika, Junying Fan, Robert V. Forest, Peng Geng, Carlos A. Guerrero, Sha Lou, Dimitri Skliar, Sarah E. Steinhardt, and Neil A. Strotman 。

2023 Organic Process Research & Development期刊年度優(yōu)秀論文獎(jiǎng)獲獎(jiǎng)?wù)吆嫌?/em>

該獎(jiǎng)項(xiàng)旨在表彰上一年度發(fā)表在 Organic Process Research & Development 期刊上優(yōu)秀文章背后的研究團(tuán)隊(duì),該團(tuán)隊(duì)展示了工藝化學(xué)領(lǐng)域和與反應(yīng)放大相關(guān)的學(xué)科的創(chuàng)造性和影響力:Jason M. Stevens博士及來(lái)自Bristol-Myers Squibb、Janssen Research and Development、Merck & Co., Inc.公司的合作者因其文章“Leveraging High-Throughput Experimentation to Drive Pharmaceutical Route Invention: A Four-Step Commercial Synthesis of Branebrutinib (BMS-986195)”而受到表彰,該文章報(bào)道了快速識(shí)別高效合成路線以制備活性藥物成分的強(qiáng)大策略。

Leveraging High-Throughput Experimentation to Drive Pharmaceutical Route Invention: A Four-Step Commercial Synthesis of Branebrutinib (BMS-986195) | Organic Process Research & Development (acs.org)

Org. Process Res. Dev . 2022, 26, 4, 1174–1183

Publication Date: February 15, 2022

https://doi.org/10.1021/acs.oprd.1c00443

掃碼閱讀獲獎(jiǎng)?wù)撐?/p>

本文的通訊作者Jason (Jay) Stevens博士來(lái)自紐約州薩拉托加泉市(Saratoga Springs),本科畢業(yè)于紐約州立大學(xué)奧斯威戈分校。他于2003年在AMRI Global開(kāi)始其工業(yè)生涯,擔(dān)任工藝化學(xué)師。2005年在北卡羅來(lái)納大學(xué)教堂山分校Michael Crimmins教授的實(shí)驗(yàn)室攻讀博士學(xué)位,在那里他完成了銀杏素的全合成工作。博士畢業(yè)后,史蒂文斯博士來(lái)到2021年諾貝爾化學(xué)獎(jiǎng)得主之一David MacMillan教授的實(shí)驗(yàn)室進(jìn)行博士后研究,在那里他開(kāi)發(fā)了一種通過(guò)協(xié)同銅-有機(jī)催化實(shí)現(xiàn)醛的對(duì)映選擇性a-烯基化的方法。Stevens博士目前在Bristol Myers Squibb公司化學(xué)工藝開(kāi)發(fā)部擔(dān)任自動(dòng)化和數(shù)據(jù)科學(xué)小組成員。

Jason (Jay) Stevens博士

下面是Stevens博士的專訪內(nèi)容

(滾動(dòng)查看全文)

What does this awar d mean to you?

Receiving this award is great recognition of our chemistry organization at Bristol Myers Squibb (BMS), our fantastic team of process chemists, engineers, analytical scientists, and the team that worked on the development of the commercial manufacturing process for branebrutinib. The Chemical Process Development department at BMS embodies a culture that challenges us to develop innovative chemistry solutions and encourages scientific curiosity to deliver molecules and processes that impact our patients’ lives. This award is a recognition that we are living up to our vision as a department and as a company.

How would you describe your research to someone outside your field of research?

Our mission is to create safe, economical, and sustainable processes to supply high quality active ingredients for the medicines we deliver to patients. We deliver early supplies of our novel therapeutics to support clinical trials and resupply the clinic as the molecule advances through the ongoing trials. Our department also develops the commercial manufacturing processes for our medicines’ active ingredient such that we can deliver increasingly innovative therapies to our patients with foundations of safety, quality, and compliance with government regulations. To do this, we often have to invent new chemistry to improve the manufacturing process as the demand for a therapeutic grows. This is to ensure the patients are supplied and that we are implementing sustainable processes with reduced costs and increased robustness.

What do you think is the biggest challenge currently in your area of research?

A current, yet fun, challenge in chemical process development is the growing complexity of the chemical compounds that we need to deliver for our patients. Our department has done work to quantify the growing complexity of the molecules we work on, yet these increasingly challenging targets continue to require efficient, safe, and robust manufacturing methods to deliver high quality medicines to our patients with speed. Thus, we are continuing to make increasingly difficult molecules with the same constraints we’ve always had. This paradigm of delivering efficient processes for complex targets under tight timelines and efficiency constraints is the focal point of the work that we published.

What is next in your research?

Our department has world-class capabilities in high-throughput experimentation (HTE), which is the use of parallel experimentation coupled with automation to run multi-dimensional, large, arrayed experiments in a rapid and highly efficient manner. Recently, we have fully embraced data science and have begun to leverage the troves of data collected using HTE over the years to inform and enhance our experimental designs. Additionally, we’re enthusiastic about coupling our existing and future automation equipment with artificial intelligence to augment our work in closed-loop systems.

Have there been any highlights in your career to date that you are especially proud of?

I am very proud of the recognition we received for the process development work that led to the commercial synthesis of branebrutinib, and I’m grateful to have worked with such an incredible team. I’m also immensely proud of our work in the area of Bayesian optimization, to develop artificial intelligence for chemical reaction optimization. I began my journey into data science in 2017, and I’m still in awe of the accomplishments that we were able to achieve with our phenomenal collaborators Professor Abigail Doyle (UCLA) and Ryan Adams (Princeton) and the impact that we’ve been able to deliver in such a short amount of time.

What would your advice be to someone just starting out in the field?

I would encourage someone starting out in the field of process development to get a broad experience in the many different areas of expertise. This would allow you to find where your passion is and to grow your network which will foster fruitful collaborations across disciplines. The people that I work with continue to inspire me every day with their creativity and passion for science. The ability to connect with people across functions has generated many exciting projects and has led to an incredibly rewarding career.

點(diǎn)擊 閱讀原文 查看Axial原文

IF 2021: 3.858

Citaions 2021: 10,273

Essential for Laboratory to Large-Scale Chemical Processing and Engineering
Organic Process Research & Development reports original work from the broad field of industrial process chemistry but also presents academic results that are relevant, or potentially relevant, to industrial applications.   The Journal aims to cover R&D from and for the fine organic chemicals and specialty chemicals industries, including pharmaceuticals, agrochemicals, electronic chemicals, flavors and fragrances, intermediates, food additives, and specialty polymers, with work from commodity chemicals, petrochemicals, and polymers being appropriate as well.

Copyright ? 2023 American Chemical Society

點(diǎn)擊“閱讀原文”

你“賞”我嗎?

版權(quán):如無(wú)特殊注明,文章轉(zhuǎn)載自網(wǎng)絡(luò),侵權(quán)請(qǐng)聯(lián)系cnmhg168#163.com刪除!文件均為網(wǎng)友上傳,僅供研究和學(xué)習(xí)使用,務(wù)必24小時(shí)內(nèi)刪除。
相關(guān)推薦